- Home
- CNK vs XENE Comparison
CNK vs XENE Comparison
Compare CNK & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNK | XENE |
|---|---|---|
| Founded | 1984 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.2B |
| IPO Year | 2007 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CNK | XENE |
|---|---|---|
| Price | $30.35 | $58.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 12 |
| Target Price | $33.70 | ★ $67.17 |
| AVG Volume (30 Days) | ★ 1.6M | 1.3M |
| Earning Date | 05-01-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.17% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.04 | N/A |
| Revenue | ★ $3,115,000,000.00 | $311,000.00 |
| Revenue This Year | $10.82 | N/A |
| Revenue Next Year | $3.68 | $2,436.26 |
| P/E Ratio | $29.62 | ★ N/A |
| Revenue Growth | ★ 2.15 | N/A |
| 52 Week Low | $21.60 | $28.19 |
| 52 Week High | $34.01 | $62.91 |
Technical Indicators
Market Signals| Indicator | CNK | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 69.12 | 65.68 |
| Support Level | $29.36 | $39.93 |
| Resistance Level | $30.88 | $59.44 |
| Average True Range (ATR) | 0.99 | 1.92 |
| MACD | 0.24 | -0.15 |
| Stochastic Oscillator | 87.70 | 87.59 |
Price Performance
Historical ComparisonAbout CNK Cinemark Holdings Inc Cinemark Holdings Inc.
Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres. Cinemark manages its business under two reportable segments: U.S. markets and international markets. The majority of its revenue is generated from the U.S. markets segment.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.